None
Conditions
Interventions
Group B (Teglitidine 0.75mg group):Intravenous injection of Tegretol fumarate 0.75 mg
Group C (Alfentanyl Group):Intravenous injection of alfentanil at a dose of 10 µg/kg
Group A (Teglitidine 1mg group):Intravenous injection of tigelydin fumarate at a dose of 1 mg
Sponsors
Liuzhou Maternity and Child Healthcare Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Patients scheduled for hysteroscopic surgery; 2. Age between 18 and 45 years old; 3. BMI ranging from 18 to 30 kg/m^2; 4. ASA grade I to II
Exclusion criteria
Exclusion criteria: 1. Severe intrauterine adhesions; 2. Congenital malformations of the uterus or cervical canal; 3. Having contraindications for general anesthesia or having a history of anesthesia accidents in the past; 4. Complicated with kidney or liver diseases, any heart-related diseases, respiratory system diseases, history of hypertension, potential difficult airway, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of respiratory depression;Incidence of intraoperative movement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic stability;Postoperative pain;Drug intervention;Postoperative adverse reactions;Anesthesia recovery rate; | — |
Countries
China
Contacts
Public ContactXiaosheng Cao
Liuzhou Maternity and Child Healthcare Hospital
Outcome results
None listed